Adapthealth Corp (AHCO) - Net Assets
Based on the latest financial reports, Adapthealth Corp (AHCO) has net assets worth $1.62 Billion USD as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($4.38 Billion) and total liabilities ($2.76 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check AHCO asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $1.62 Billion |
| % of Total Assets | 37.07% |
| Annual Growth Rate | 386.88% |
| 5-Year Change | 461.92% |
| 10-Year Change | N/A |
| Growth Volatility | 353329.92 |
Adapthealth Corp - Net Assets Trend (2017–2024)
This chart illustrates how Adapthealth Corp's net assets have evolved over time, based on quarterly financial data. Also explore total assets of Adapthealth Corp for the complete picture of this company's asset base.
Annual Net Assets for Adapthealth Corp (2017–2024)
The table below shows the annual net assets of Adapthealth Corp from 2017 to 2024. For live valuation and market cap data, see AHCO market cap.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $1.58 Billion | +7.60% |
| 2023-12-31 | $1.47 Billion | -32.03% |
| 2022-12-31 | $2.16 Billion | +4.41% |
| 2021-12-31 | $2.07 Billion | +635.88% |
| 2020-12-31 | $280.85 Million | +1755.23% |
| 2019-12-31 | $15.14 Million | -93.84% |
| 2018-12-31 | $245.55 Million | +1010102.37% |
| 2017-12-31 | $24.31K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Adapthealth Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 56217730700.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $13.00K | 0.00% |
| Other Comprehensive Income | $2.25 Million | 0.14% |
| Other Components | $2.13 Billion | 135.64% |
| Total Equity | $1.57 Billion | 100.00% |
Adapthealth Corp Competitors by Market Cap
The table below lists competitors of Adapthealth Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Ennoconn Corp
TW:6414
|
$1.40 Billion |
|
SHANGHAI FU. MIC.H YC-10
F:FUD
|
$1.40 Billion |
|
OSK Holdings Bhd
KLSE:5053
|
$1.40 Billion |
|
Reit 1
TA:RIT1
|
$1.40 Billion |
|
Tong Yang Industry Co Ltd
TW:1319
|
$1.39 Billion |
|
Golden Ocean Group Limited
F:KT31
|
$1.39 Billion |
|
PNC Process Systems Co Ltd
SHG:603690
|
$1.39 Billion |
|
Huafa Industrial Co Ltd Zhuhai
SHG:600325
|
$1.39 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Adapthealth Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,458,454,000 to 1,571,145,000, a change of 112,691,000 (7.7%).
- Net income of 90,422,000 contributed positively to equity growth.
- Share repurchases of 2,065,999 reduced equity.
- Other comprehensive income decreased equity by 2,103,000.
- Other factors increased equity by 26,437,999.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $90.42 Million | +5.76% |
| Share Repurchases | $2.07 Million | -0.13% |
| Other Comprehensive Income | $-2.10 Million | -0.13% |
| Other Changes | $26.44 Million | +1.68% |
| Total Change | $- | 7.73% |
Book Value vs Market Value Analysis
This analysis compares Adapthealth Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.14x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 16931.85x to 1.14x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | $0.00 | $13.17 | x |
| 2018-12-31 | $7.86 | $13.17 | x |
| 2019-12-31 | $-3.25 | $13.17 | x |
| 2020-12-31 | $6.76 | $13.17 | x |
| 2021-12-31 | $15.50 | $13.17 | x |
| 2022-12-31 | $15.48 | $13.17 | x |
| 2023-12-31 | $10.85 | $13.17 | x |
| 2024-12-31 | $11.59 | $13.17 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Adapthealth Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 5.76%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 2.77%
- • Asset Turnover: 0.73x
- • Equity Multiplier: 2.86x
- Recent ROE (5.76%) is above the historical average (-9.69%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | -2.84% | 0.00% | 619.93x | 12.78x | $-3.12K |
| 2018 | 0.85% | 0.60% | 1.36x | 1.03x | $-22.47 Million |
| 2019 | 0.00% | -4.03% | 2.32x | 0.00x | $-14.01 Million |
| 2020 | -45.54% | -15.30% | 0.58x | 5.11x | $-197.12 Million |
| 2021 | 7.57% | 6.36% | 0.47x | 2.55x | $-50.02 Million |
| 2022 | 3.22% | 2.33% | 0.57x | 2.43x | $-145.80 Million |
| 2023 | -46.55% | -21.21% | 0.71x | 3.09x | $-824.74 Million |
| 2024 | 5.76% | 2.77% | 0.73x | 2.86x | $-66.69 Million |
Industry Comparison
This section compares Adapthealth Corp's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $2,676,198,212
- Average return on equity (ROE) among peers: -59.24%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Adapthealth Corp (AHCO) | $1.62 Billion | -2.84% | 1.70x | $1.39 Billion |
| Abbott Laboratories (ABT) | $24.08 Billion | 18.37% | 0.83x | $155.56 Billion |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-95.88 Million | 0.00% | 0.00x | $21.60 Million |
| Aethlon Medical Inc (AEMD) | $9.29 Million | -84.45% | 0.15x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $105.73 Million | -116.68% | 0.61x | $903.35K |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $15.99 Million |
| Allurion Technologies, Inc. (ALUR) | $-70.49 Million | 0.00% | 0.00x | $8.10 Million |
| Autonomix Medical, Inc. Common Stock (AMIX) | $644.00K | -309.01% | 0.34x | $4.22 Million |
| Artivion Inc (AORT) | $30.20 Million | 15.56% | 0.78x | $1.73 Billion |
| Apyx Medical Inc (APYX) | $22.89 Million | 2.69% | 0.23x | $125.55 Million |
About Adapthealth Corp
AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. The company offers sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and … Read more